Taiga Nishihori

机构：Moffitt Cancer Center · ORCID：0000-0002-2621-7924

发表论文 697 篇 · 总被引 10525 次 · h-index 54

代表论文

• Enhancing the safety of ciltacabtagene autoleucel in relapsed multiple myeloma (MM): Identification of potentially modifiable risk-factors associated with delayed neurotoxicity and non-relapse mortality (2025 · Blood · 被引 7)
• Bridging therapy response and low pre-lymphodepletion plasma cell burden are associated with improved safety and efficacy outcomes of ciltacabtagene autoleucel in multiple myeloma (2025 · Blood · 被引 4)
• Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes (2025 · Blood Advances · 被引 2)
• Barriers and bridges: Real-world CAR T delivery across US oncology practices (2025 · Blood · 被引 2)
• Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis (2025 · Bone Marrow Transplantation · 被引 1)
• Identifying candidates for outpatient administration of ciltacabtagene autoleucel (Cilta-cel) in relapsed-refractory multiple myeloma (RRMM) (2025 · Blood · 被引 1)